ArticleFluids and barriers of the CNS2026
Clinical characteristics and outcomes after shunt surgery in idiopathic normal pressure hydrocephalus with or without prior cerebrospinal fluid tap testing: a single-center follow-up study of 481 patients.
Article in Fluids and barriers of the CNS, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe cerebrospinal fluid tap test (CSF TT) is a commonly used predictive test for selecting patients with idiopathic normal pressure hydrocephalus (iNPH) for shunt surgery, but low sensitivity rate carries the risk of excluding individuals from effective treatment. We explored clinical characteristics and postoperative outcomes of iNPH patients shunted based solely on clinical and MRI findings compared with those shunted following a positive CSF TT.
methodsA total of 481 consecutive shunt operated iNPH patients were assessed in a team-based setting. Patients were categorized into two groups: those shunted based on typical clinical symptoms and MRI features without a supplementary test (NoTT, n = 390) and those shunted based on a positive CSF TT (TT, n = 91). Baseline clinical data, including comorbidities, and 5-month postoperative outcomes were assessed using the Gothenburg iNPH Scale and the modified Rankin scale (mRS).
resultsBaseline characteristics and clinical measures were similar across groups, except that TT patients had more prevalent other concurrent neurological conditions (37% vs. 11%) and a longer delay between diagnosis and surgery (median 198 vs. 126 days) (both p < 0.001). Overall improvement (≥ 5-point postoperative increase in the total iNPH Scale) was observed in 70.9% of NoTT patients compared with 58.6% of TT patients (percentage point difference = 12.3; 95% CI = 0.3, 24.3; p = 0.044) while postoperative deterioration (defined as ≥ 5-point decrease on the iNPH Scale) was significantly more common in TT group (22.9%) than in the NoTT (10.7%) (percentage point difference = 12.1; 95% CI = 3.5, 20.7; p = 0.006). After adjusting for concurrent neurological disorder and surgical delay, improvement in continence (percentage point difference = 13.5, 95% CI = 0.7, 26.3) was better in NoTT patients (p = 0.039).
conclusionsThis real-world study shows that a majority of iNPH patients can be routinely assessed by a clinical team and shunted with favorable outcomes without a supplementary predictive tap test. The worse outcomes seen in TT patients are likely to be due to higher prevalence of neurological comorbidity and delayed time to surgery. We suggest that the tap test may be reserved for difficult patients with suspected iNPH including those who present with concurrent other neurological disorders.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.